A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Locally Advanced or Metastatic Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Jun Guo)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer

Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

Urothelial Carcinoma · Advanced Urothelial Carcinoma · Urothelial Carcinoma Recurrent

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Guangzhou, China

Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma

Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE2

Philadelphia, United States · Philadelphia, United States

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer · Advanced/Metastatic Urothelial Cancer · Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Fayetteville, United States · Rogers, United States